Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer

Published:2018-09 Issue:3 Volume:128 Page:498-504
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Contreras Jessika A.,Lin Alexander J.,Weiner Ashley,Speirs Christina,Samson Pamela,Mullen Daniel,Campian Jian,Bradley Jeffrey,Roach Michael,Robinson Clifford

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference34 articles.

1. Sequential vs concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III Trial RTOG 9410;Curran;JNCI J Natl Cancer Inst,2011

2. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

3. Late cardiotoxicity after treatment for Hodgkin lymphoma;Aleman;Blood,2007

4. Risk of ischemic heart disease in women after radiotherapy for breast cancer;Darby;N Engl J Med,2013

5. Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer;Speirs;J Thorac Oncol,2017

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher immune cell radiation dose is correlated with poor tumor control and survival in patients with non-small cell lung cancer receiving postoperative radiotherapy;BMC Cancer;2024-08-08

2. A roadmap for modelling radiation‐induced cardiac disease;Journal of Medical Imaging and Radiation Oncology;2024-07-10

3. Predicting radiation‐induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy;Medical Physics;2024-06-04

4. Efficacy of Shenglin decoction in preventing acute severe lymphocytopenia in patients with non-small cell lung cancer undergoing concurrent chemoradiotherapy: a study protocol for a randomized controlled trial;Frontiers in Oncology;2024-05-08

5. Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy;The Clinical Respiratory Journal;2024-04-29